US Patent Issued to BMG (BRITISH MEDICAL GROUP) on Sept. 9 for "Antimicrobial and anticancer cationic phthalocyanine compounds" (British Inventor)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,177, issued on Sept. 9, was assigned to BMG (BRITISH MEDICAL GROUP) Ltd. (Cambridge, Great Britain).

"Antimicrobial and anticancer cationic phthalocyanine compounds" was invented by Paul Wight (Manchester, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "Substituted phthalocyanines for the generation of singlet oxygen in which one or more of the substituents bear acationically charged N-alkylated pyridine."

The patent was filed on April 9, 2019, under Application No. 17/046,108.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetaht...